Amphotericin B: is a lipid-formulation gold standard feasible?
Spellberg
Brad
B
Witt
Mallory D
MD
Beck
C Keith
CK
D000666:Amphotericin B / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D003362:Cost-Benefit Analysis; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D009181:Mycoses / Q000188:drug therapy*
D000935:Antifungal Agents; D008055:Lipids; D000666:Amphotericin B